How should we be defining a meaningful clinical response to TNF-blockers in ankylosing spondylitis patients?

M Stone, D Cortinovis, A G Raj, A Maetzel, R Inman, V Lapp, D Beaton

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)544-544
Number of pages1
JournalAnnals of the Rheumatic Diseases
Publication statusPublished - 2006

Bibliographical note

ID number: ISI:000249372502252

Cite this